These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22960250)

  • 61. Selective Disruption of Inhibitory Synapses Leading to Neuronal Hyperexcitability at an Early Stage of Tau Pathogenesis in a Mouse Model.
    Shimojo M; Takuwa H; Takado Y; Tokunaga M; Tsukamoto S; Minatohara K; Ono M; Seki C; Maeda J; Urushihata T; Minamihisamatsu T; Aoki I; Kawamura K; Zhang MR; Suhara T; Sahara N; Higuchi M
    J Neurosci; 2020 Apr; 40(17):3491-3501. PubMed ID: 32265258
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Glutamatergic nervous system degeneration in a C. elegans Tau
    Choudhary B; Mandelkow E; Mandelkow EM; Pir GJ
    Neurobiol Dis; 2018 Sep; 117():189-202. PubMed ID: 29894752
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neuroprotective effects of low fat-protein diet in the P301L mouse model of tauopathy.
    Buccarello L; Grignaschi G; Di Giancamillo A; Domeneghini C; Melcangi RC; Borsello T
    Neuroscience; 2017 Jun; 354():208-220. PubMed ID: 28456717
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pin1 has opposite effects on wild-type and P301L tau stability and tauopathy.
    Lim J; Balastik M; Lee TH; Nakamura K; Liou YC; Sun A; Finn G; Pastorino L; Lee VM; Lu KP
    J Clin Invest; 2008 May; 118(5):1877-89. PubMed ID: 18431510
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Aβ and tau pathology in transgenic mouse models of Alzheimer's disease.
    Shao CY; Mirra SS; Sait HB; Sacktor TC; Sigurdsson EM
    Acta Neuropathol; 2011 Sep; 122(3):285-92. PubMed ID: 21630115
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy.
    Hansen HH; Barkholt P; Fabricius K; Jelsing J; Terwel D; Pyke C; Knudsen LB; Vrang N
    Brain Res; 2016 Mar; 1634():158-170. PubMed ID: 26746341
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Tau and Axonal Transport Misregulation in Tauopathies.
    Combs B; Mueller RL; Morfini G; Brady ST; Kanaan NM
    Adv Exp Med Biol; 2019; 1184():81-95. PubMed ID: 32096030
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation.
    Reilly P; Winston CN; Baron KR; Trejo M; Rockenstein EM; Akers JC; Kfoury N; Diamond M; Masliah E; Rissman RA; Yuan SH
    Neurobiol Dis; 2017 Oct; 106():222-234. PubMed ID: 28610892
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Filamentous tau in oligodendrocytes and astrocytes of transgenic mice expressing the human tau isoform with the P301L mutation.
    Lin WL; Lewis J; Yen SH; Hutton M; Dickson DW
    Am J Pathol; 2003 Jan; 162(1):213-8. PubMed ID: 12507904
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice.
    Leroy K; Bretteville A; Schindowski K; Gilissen E; Authelet M; De Decker R; Yilmaz Z; Buée L; Brion JP
    Am J Pathol; 2007 Sep; 171(3):976-92. PubMed ID: 17690183
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Studying tau protein propagation and pathology in the mouse brain using adeno-associated viruses.
    Wegmann S; Bennett RE; Amaral AS; Hyman BT
    Methods Cell Biol; 2017; 141():307-322. PubMed ID: 28882310
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmacogenetic neuronal stimulation increases human tau pathology and trans-synaptic spread of tau to distal brain regions in mice.
    Schultz MK; Gentzel R; Usenovic M; Gretzula C; Ware C; Parmentier-Batteur S; Schachter JB; Zariwala HA
    Neurobiol Dis; 2018 Oct; 118():161-176. PubMed ID: 30049665
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy.
    Carroll JC; Iba M; Bangasser DA; Valentino RJ; James MJ; Brunden KR; Lee VM; Trojanowski JQ
    J Neurosci; 2011 Oct; 31(40):14436-49. PubMed ID: 21976528
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies.
    Zilka N; Korenova M; Novak M
    Acta Neuropathol; 2009 Jul; 118(1):71-86. PubMed ID: 19238406
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Amphiphysin-1 protein level changes associated with tau-mediated neurodegeneration.
    De Jesús-Cortés HJ; Nogueras-Ortiz CJ; Gearing M; Arnold SE; Vega IE
    Neuroreport; 2012 Nov; 23(16):942-6. PubMed ID: 22975846
    [TBL] [Abstract][Full Text] [Related]  

  • 76. AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies.
    Vingtdeux V; Davies P; Dickson DW; Marambaud P
    Acta Neuropathol; 2011 Mar; 121(3):337-49. PubMed ID: 20957377
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ectopic Expression Induces Abnormal Somatodendritic Distribution of Tau in the Mouse Brain.
    Kubo A; Ueda S; Yamane A; Wada-Kakuda S; Narita M; Matsuyama M; Nomori A; Takashima A; Kato T; Onodera O; Goto M; Ito M; Tomiyama T; Mori H; Murayama S; Ihara Y; Misonou H; Miyasaka T
    J Neurosci; 2019 Aug; 39(34):6781-6797. PubMed ID: 31235644
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Trans-synaptic spread of tau pathology in vivo.
    Liu L; Drouet V; Wu JW; Witter MP; Small SA; Clelland C; Duff K
    PLoS One; 2012; 7(2):e31302. PubMed ID: 22312444
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Developmental Pathogenicity of 4-Repeat Human Tau Is Lost with the P301L Mutation in Genetically Matched Tau-Transgenic Mice.
    Gamache JE; Kemper L; Steuer E; Leinonen-Wright K; Choquette JM; Hlynialuk C; Benzow K; Vossel KA; Xia W; Koob MD; Ashe KH
    J Neurosci; 2020 Jan; 40(1):220-236. PubMed ID: 31685653
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Differential regional distribution of phosphorylated tau and synapse loss in the nucleus accumbens in tauopathy model mice.
    Kambe T; Motoi Y; Inoue R; Kojima N; Tada N; Kimura T; Sahara N; Yamashita S; Mizoroki T; Takashima A; Shimada K; Ishiguro K; Mizuma H; Onoe H; Mizuno Y; Hattori N
    Neurobiol Dis; 2011 Jun; 42(3):404-14. PubMed ID: 21324362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.